跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PROLIDE - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
PROLIDE
Approved
STANDARD
PROLIDE
Celon Laboratories Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
a4bfff57ae5ba617
Company
Celon Laboratories Limited
Type
Standard
Approval Details
Approval Id
a4bfff57ae5ba617
Drug Approval Philippines Name
PROLIDE
Product Name
PROLIDE
Registration Number
DRP-7243
Brand Name
PROLIDE
Generic Name
Leuprorelin Acetate
Dosage Form
Lyophilized Powder for Injection
Dosage Strength
11.25 mg
Manufacturer
Celon Laboratories Limited
Importer
I.E. MEDICA INC.
Distributor
I.E. MEDICA INC.
Issuance Date
24 June 2022
Expiry Date
21 June 2027
Pharmacologic Category
Antineoplastic
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
a4bfff57ae5ba617
Type
Standard
Back to Philippines FDA Approvals